Page last updated: 2024-09-03

sn 23862 and Cancer of Prostate

sn 23862 has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ay, M; Çelik, A; Gülhan, ÜG; Güngör, T; Hacıoğlu, N; Köçkar, F; Önder, FC; Tok, TT; Tokay, E	1

Other Studies

1 other study(ies) available for sn 23862 and Cancer of Prostate

Article	Year
Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer. European journal of medicinal chemistry, 2020, Feb-01, Volume: 187 Topics: Aniline Compounds; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Genetic Therapy; Humans; Male; Models, Molecular; Molecular Structure; Nitroreductases; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship	2020

Article

Year

Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.

European journal of medicinal chemistry, 2020, Feb-01, Volume: 187

Topics: Aniline Compounds; Antineoplastic Agents; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Genetic Therapy; Humans; Male; Models, Molecular; Molecular Structure; Nitroreductases; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship

2020